scholarly journals A Review of Most Relevant Complications of Transcatheter Aortic Valve Implantation

2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Siyamek Neragi-Miandoab ◽  
Robert E. Michler
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Surgical Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Edwards Sapien ◽  
Risk Patients ◽  
Edwards Sapien Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation ◽  
Transapical Approach

Transcatheter aortic valve implantation (TAVI) has emerged for treating aortic stenosis in patients who are poor candidates for surgical aortic valve replacement. Currently, the balloon-expandable Edwards Sapien valve—which is usually implanted via a transfemoral or transapical approach—and the self-expanding CoreValve ReValving system—which is designed for retrograde application—are the most widely implanted valves worldwide. Although a promising approach for high-risk patients, the indication may be expanded to intermediate- and eventually low-risk patients in the future; however, doing so will require a better understanding of potential complications, risk factors for these complications, and strategies to individualize each patient to a different access route and a specific valve. This paper reviews the most relevant complications that may occur in patients who undergo catheter-based aortic valve implantation.

scholarly journals Emergency Transcatheter Aortic Valve Implantation in A Patient with The Assistance of Intra-Aortic Balloon Pump

2021 ◽  
Vol 4 (3) ◽  
pp. 157-161
Author(s):  
Yan Xu ◽  
Pengkun Zhang ◽  
Dengfeng Fang
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Standard Treatment ◽  
Multiple Organ ◽  
Surgical Aortic Valve Replacement ◽  
Intra Aortic Balloon Pump ◽  
Transcatheter Aortic Valve ◽  
Risk Patients ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Surgical aortic valve replacement (SAVR) is considered the gold-standard treatment for patients with severe aortic valve stenosis (AS), yet 30% are considered inappropriate for SAVR on account of the advanced age and multiple comorbidities. Transcatheter aortic valve implantation (TAVI) provides an option for high-risk patients with severe AS, especially for those accompanied with acute cardiogenic shock and multiple organ dysfunction. Herein, we presented a case of a patient resuscitated successfully with TAVI in combination with intra-aortic balloon pump.

Three-Year Survival Comparison between Transcatheter and Surgical Aortic Valve Replacement for Intermediate- and Low-Risk Patients

2018 ◽  
Vol 13 (3) ◽  
pp. 153-162 ◽  
Author(s):  
Juan A. Siordia ◽  
Jackquelin M. Loera ◽  
Matt Scanlon ◽  
Jessie Evans ◽  
Peter A. Knight
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Implantation ◽  
Low Risk ◽  
Surgical Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Risk Patients ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Transcatheter aortic valve implantation is a suitable therapeutic intervention for patients deemed inoperable or high risk for surgical aortic valve replacement. Current investigations question whether it is a suitable alternative to surgery for intermediate- and low-risk patients. The following meta-analysis presents a comparison between transcatheter versus surgical aortic valve replacement in patients that are intermediate and low risk for surgery. Articles were collected via an electronic search using Google Scholar and PubMed. Articles of interest included studies comparing the survival of intermediate- and low-risk patients undergoing transcatheter aortic valve implantation to those undergoing surgical aortic valve replacement. Primary end points included 1-, 2-, and 3-year survival. Secondary end points included postintervention thromboembolic events, stroke, transient ischemic attacks, major vascular complications, permanent pacemaker implantation, life-threatening bleeding, acute kidney injury, atrial fibrillation, and moderate-to-severe aortic regurgitation. Six studies met the criteria for the meta-analysis. One- and two-year survival comparisons showed no difference between the two interventions. Surgical aortic valve replacement, however, presented with favorable 3-year survival compared with the transcatheter approach. Transcatheter aortic valve implantation had more major vascular complications, permanent pacemaker implantation, and moderate-to-severe aortic regurgitation rates compared with surgery. Surgical aortic valve replacement presented more life-threatening bleeding, acute kidney injury, and atrial fibrillation compared with a transcatheter approach. There was no statistical difference between the two approaches in terms of thromboembolic events, strokes, or transient ischemic attack rates. Surgical aortic valve replacement presents favorable 3-year survival rates compared with transcatheter aortic valve implantation.

Transcatheter aortic valve implantation and the management of coronary artery disease

2018 ◽  
pp. 600-606
Author(s):  
Muhammed Zeeshan Khawaja ◽  
Simon Redwood
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Surgical Aortic Valve Replacement ◽  
Transcatheter Aortic Valve ◽  
Risk Patients ◽  
Aortic Valve Implantation ◽  
Artery Disease ◽  
Valve Implantation

The advent of transcatheter aortic valve implantation (TAVI) has provoked a paradigm shift in the treatment of senile calcific aortic stenosis (AS), the most common valvular disease in the developed world. Its benefits in high-risk and inoperable patients and its comparable outcomes to surgical aortic valve replacement are well established, and there is now evidence supporting use of the technique in intermediate-risk patients. AS often coexists with coronary artery disease (CAD) and, in seeking to further improve outcomes and minimize risks in the TAVI procedure, the management of concomitant CAD is an important consideration.

Transaortic transcatheter aortic valve implantation using edwards sapien valve

2011 ◽  
Vol 79 (5) ◽  
pp. 733-740 ◽  
Author(s):  
Vinayak Bapat ◽  
Muhammed Z. Khawaja ◽  
Rizwan Attia ◽  
Ashok Narayana ◽  
Karen Wilson ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Transcatheter Aortic Valve ◽  
Edwards Sapien ◽  
Edwards Sapien Valve ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Aortic Valve Implantation – Developments and Challenges

2010 ◽  
Vol 5 (1) ◽  
pp. 77
Author(s):  
Lutz Buellesfeld ◽  
Ulrich Gerckens ◽  
◽  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Surgical Aortic Valve Replacement ◽  
Reduced Ejection Fraction ◽  
Arterial Access ◽  
Transcatheter Aortic Valve ◽  
Prior Surgery ◽  
Aortic Valve Implantation ◽  
Valve Implantation ◽  
Transapical Approach

Surgical aortic valve replacement is the reference standard for patients with symptomatic severe aortic valve stenosis, but it is associated with a high surgical risk in numerous patient subgroups who present with co-morbidities such as reduced ejection fraction, prior surgery or advanced age. Transcatheter aortic valve implantation utilising stent-based prostheses has emerged as a promising new option in recent years and has been used by a number of operators in different centres, with incremental success in line with procedural experience. This has sparked the evolution of more sophisticated techniques, ranging from the initial anterograde approach to the currently used retrograde approach utilising arterial access or a transapical approach. The technology has also significantly improved over the years, with the development of delivery catheters with smaller profiles and better prostheses with various size options. These developments in the field of transcatheter aortic valve implantation and future perspectives will be discussed in this article.

Sign in / Sign up

Export Citation Format

Share Document